EHA Endorsement of ESMO Clinical Practice Guidelines for Diagnosis, Treatment, and Follow-up of Chronic Lymphocytic Leukemia

EHA Endorsement of ESMO Clinical Practice Guidelines for Diagnosis, Treatment, and Follow-up of Chronic Lymphocytic Leukemia

Bibliographic Details
Main Authors:	Barbara Eichhorst, Paolo Ghia, on behalf of the EHA Guidelines Committee
Format:	Article
Language:	English
Published:	Wolters Kluwer 2021-01-01
Series:	HemaSphere
Online Access:	http://journals.lww.com/10.1097/HS9.0000000000000520

Similar Items

EHA Endorsement of ESMO Clinical Practice Guidelines for Diagnosis, Treatment, and Follow-up for Waldenström’s Macroglobulinemia
by: Philipp B. Staber, et al.
Published: (2021-10-01)

EHA Endorsement of ESMO Clinical Practice Guidelines for Marginal Zone Lymphomas
by: Marco Ladetto, et al.
Published: (2020-04-01)

EHA Endorsement of ESMO Clinical Practice Guidelines for Newly Diagnosed and Relapsed Mantle Cell Lymphoma
by: Kim Linton, et al.
Published: (2020-10-01)

Multiple Myeloma: EHA-ESMO Clinical Practice Guidelines for Diagnosis, Treatment and Follow-up
by: Meletios A. Dimopoulos, et al.
Published: (2021-02-01)

EHA Endorsement of the European Guidelines for Myelodysplastic Syndromes, MDS-RIGHT
by: Sabine Blum, et al.
Published: (2021-09-01)

EHA Endorsement of ESMO Clinical Practice Guidelines for Newly Diagnosed and Relapsed Follicular Lymphoma
by: Marco Ladetto, et al.
Published: (2021-05-01)

Correction Notice: Multiple Myeloma: EHA-ESMO Clinical Practice Guidelines for Diagnosis, Treatment and Follow-up
Published: (2021-04-01)

Bladder cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up ☆
by: Bellmunt, J., et al.
Published: (2022)

EHA/ESMO Clinical Practice Guidelines for the Management of Malignant Lymphoma: Recommendations for the Second Phase of the COVID-19 Pandemic
by: Martin Dreyling, et al.
Published: (2021-02-01)

An excerpt of 2016 ESMO clinical practice guidelines for diagnosis, treatment and follow-up in biliary cancer
by: FANG Long, et al.
Published: (2017-02-01)

Management of orphan symptoms: ESMO Clinical Practice Guidelines for diagnosis and treatment†
by: P Bossi, et al.
Published: (2020-12-01)

Hodgkin Lymphoma: Comments on ESMO Clinical Practice Guidelines
by: Igor Aurer, et al.
Published: (2020-08-01)

EHA Endorsement of the Global Guideline for the Diagnosis and Management of Rare Mold Infection: An Initiative of the European Confederation of Medical Mycology in Cooperation With International Society for Human and Animal Mycology and American Society for Microbiology
by: Rosanne Sprute, et al.
Published: (2021-03-01)

EHA Endorsement of the Global Guideline for the Diagnosis and Management of Rare Yeast Infections: An Initiative of the European Confederation of Medical Mycology in Cooperation With the International Society for Human and Animal Mycology and American Society for Microbiology
by: Jannik Stemler, et al.
Published: (2021-10-01)

Guidelines for diagnosis and treatment of chronic lymphocytic leukemia
by: Samo Zver
Published: (2010-06-01)

Management of breathlessness in patients with cancer: ESMO Clinical Practice Guidelines†
by: Sara Booth, et al.
Published: (2020-12-01)

Affordability of Medicines a Top Priority for EHA: Toward a Fair Pricing Model for Innovative Medicines
by: Anton Hagenbeek, et al.
Published: (2017-12-01)

Novel Agents in Chronic Lymphocytic Leukemia: New Combination Therapies and Strategies to Overcome Resistance
by: Moritz Fürstenau, et al.
Published: (2021-03-01)

The EHA Research Roadmap: Anemias
by: Achille Iolascon, et al.
Published: (2021-07-01)

The EHA Research Roadmap: Platelet Disorders
by: Carlo Balduini, et al.
Published: (2021-07-01)

Double Hit Lymphoma Diagnosis and Treatment in Europe—A Cross-Sectional Survey of Clinical Practice by the EHA Lymphoma Working Party (EHA LyG)
by: Igor Aurer, et al.
Published: (2020-12-01)

The EBMT/EHA CAR-T Cell Handbook
Published: (2022)

The EBMT/EHA CAR-T Cell Handbook
Published: (2022)

ESMO Symposium on Signalling Pathways in Cancer
by: Daura Mella
Published: (2015-03-01)

Guidelines for Diagnosis and Treatment of Chronic Lymphocytic Leukemia. Krohem B-Cll 2017
by: Vlatko Pejša, et al.
Published: (2018-01-01)

EHA Research Roadmap on Hemoglobinopathies and Thalassemia: An Update
by: Achille Iolascon, et al.
Published: (2019-06-01)

Telemedicine networks of EHAS Foundation in Latin America
by: Ignacio ePrieto-Egido, et al.
Published: (2014-10-01)

Correction Notice: The EHA Research Roadmap: Anemias
Published: (2021-10-01)

The EHA Research Roadmap: Malignant Myeloid Diseases
by: Hartmut Döhner, et al.
Published: (2021-09-01)

EHA2021 Virtual Congress Abstract Book
Published: (2021-06-01)

Modeling the Leukemia Microenviroment In Vitro
by: Cristina Scielzo, et al.
Published: (2020-12-01)

1. simpozij ESMO o raku in prehrani
by: Nada Rotovnik-Kozjek
Published: (2009-06-01)

ESMO's new direction in supportive and palliative care
by: Cherny Nathan I.
Published: (2004-01-01)

ESMO Open: news in breast cancer 2019
by: Daniele Santini, et al.
Published: (2020-05-01)

Fair Pricing of Innovative Medicines: An EHA Position Paper
by: Anton Hagenbeek, et al.
Published: (2020-10-01)

The EHA Research Roadmap: Blood Coagulation and Hemostatic Disorders
by: Sabine Eichinger, et al.
Published: (2021-10-01)

ESMO-Magnitude of Clinical Benefit Scale (MCBS) group
by: Teresa Amaral
Published: (2019-09-01)

Access to Affordable Orphan Medicines in Europe: An EHA Position Paper
by: Giampaolo Merlini, et al.
Published: (2020-10-01)

Personalized Treatment for Hematologic Diseases in Europe: An EHA Position Paper
by: Ulrich Jäger, et al.
Published: (2020-10-01)

EHA Guidance Document The process of CAR-T cell therapy in Europe
Published: (2019-08-01)